BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum BioMark
Form 7 Monthly Progress Report December 2025 Name of Listed Issuer: Trading Symbol: Number of
Form 7 Monthly Progress Report December 2025 Name of Listed Issuer: Trading Symbol: Number of
Form 7 Monthly Progress Report December 2025 Name of Listed Issuer: Trading Symbol: Number of
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2